Amgen

Open: 276.3 Close: 272.86 Change: -3.44

How to know if Amgen Company Inc is a risky investment without reading the whole internet.

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, share, quarter, second, dividend, report, Change, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, beating the Zacks Consensus Estimate of $3.66. Amgen closed the acquisition of Horizon Therapeutics for $27.8 billion on Oct 6, 2023. Board of Directors declares $2.25 per share.

Today's News

Amgen announces 2024 second quarter dividend. Board of Directors declares $2.25 per share dividend for second quarter of 2024. Amgen reported fourth-quarter 2023 adjusted earnings of $4.71 per share, which beat the Zacks Consensus Estimate of $3.66. Amgen closed the acquisition of Horizon Therapeutics for $27.8 billion on Oct 6, 2023. Amgen to present at the 44th Annual TD Cowen Health Care Conference at 9:10 a.m. Peter Griffith executive vice president and chief financial officer at Amgen, and Paul Burton senior vice president. The oral ETC-1002 may not be as effective as the PCSK9 drugs, including the newly-approved Praluent. Amgen will host a webcasted call at 1:00 p.m. on February 19 February. Amgen is hosting an inaugural 18-month manufacturing apprenticeship at the site. Amgen is an Equal Opportunity Employer and will consider all qualified applicants for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, protected veteran status, or disability status. The U.S. Supreme Court on Friday agreed to review Section 112 of the Patent Act. Amgen (AMGN) reported earnings of $4.71 per share, beating the Zacks Consensus Estimate of $3.83 per share. Amgen is an Equal Opportunity Employer. Amgen reports fourth quarter and full year 2023 financial results. Prolia sales are second only to etanercept (Enbrel) for Amgen, which faces biosimilar competition in 2029. Amgen to present at the 42nd annual j.p. morgan healthcare conference. Amgen is providing this information as of the date of this news release and does not undertake any obligation to update any forward-looking statements. Amgen announced that its Board of Directors declared a $2.25 per share dividend for the second quarter of 2024. General Dynamics today declared a regular quarterly dividend of $1.42 per share on the companys common stock, payable May 10, 2024. Amgen announced it will report its fourth quarter and full year 2023 financial results on February 6, 2024. Amgen Opens its most advanced manufacturing site in New Albany, Ohio, located in Central Ohio. Amgen is a leader in biotechnology industry. Zacks 20% Financials Quarterly Annual Name Revenue Change Gross Change EBITDA Change EbitDA Change

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

How much time have you spent trying to decide whether investing in Amgen? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, share, quarter, second, dividend, report, Change, and the most common words in the summary are: amgen, stock, market, report, news, top, overview, . One of the sentences in the summary was: Board of Directors declares $2.25 per share.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #stock #market #report #news #top #overview.